GSA Capital Partners’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-23,433
| Closed | -$722K | – | 1561 |
|
|
2021
Q3 | $722K | Buy |
23,433
+828
| +4% | +$25.5K | 0.07% | 479 |
|
|
2021
Q2 | $734K | Buy |
22,605
+19,147
| +554% | +$622K | 0.08% | 385 |
|
|
2021
Q1 | $131K | Buy |
3,458
+1,773
| +105% | +$67.2K | 0.02% | 977 |
|
|
2020
Q4 | $80K | Buy |
+1,685
| New | +$80K | 0.01% | 1116 |
|
|
2020
Q1 | – | Sell |
-4,540
| Closed | -$232K | – | 1247 |
|
|
2019
Q4 | $232K | Buy |
+4,540
| New | +$232K | 0.03% | 1179 |
|
|
2019
Q3 | – | Sell |
-5,403
| Closed | -$299K | – | 1512 |
|
|
2019
Q2 | $299K | Buy |
+5,403
| New | +$299K | 0.03% | 1008 |
|
|
2018
Q4 | – | Sell |
-42,655
| Closed | -$3.45M | – | 1501 |
|
|
2018
Q3 | $3.45M | Buy |
42,655
+21,702
| +104% | +$1.75M | 0.19% | 59 |
|
|
2018
Q2 | $1.83M | Buy |
+20,953
| New | +$1.83M | 0.09% | 322 |
|